Overview
Portfolio
More
Bluestonevp
Portfolio
8+
Employees
N/A
Founded
N/A
AUM
≈ $8.9M
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
BlueStone Life Science Innovation & Technology Fund
Vintage 2019 • $8.9M
Sources
Bluestonevp
Portfolio
8+
Employees
N/A
Founded
N/A
AUM
≈ $8.9M
Funds
BlueStone Life Science Innovation & Technology Fund · Vintage 2019 • $8.9M
Showing 5 of 5 matched portfolio companies
Akadeum develops the Alerion™ Microbubble Cell Separation System, which utilizes microbubble technology for negative selection and cell depletion workflows to isolate healthier cells from biological samples. This system enhances cell viability and recovery while increasing scalability, addressing the need for more efficient and effective cell therapy manufacturing processes.
CND Life Sciences offers the Syn-One Test®, a skin biopsy-based diagnostic tool that quantifies phosphorylated alpha-synuclein to assist in the diagnosis of synucleinopathies, including Parkinson's disease. This evidence-based test provides clinicians with over 95% sensitivity and specificity, addressing the challenge of accurately diagnosing these complex neurodegenerative disorders.
Founded 2017
500+
Approximate amount of employees
Funding: $15.8M
Rough estimate of the amount of funding raised
Funding: $15.8M
Rough estimate of the amount of funding raised
GT Medical Technologies offers GammaTile Therapy, a surgically targeted radiation treatment for patients with operable brain tumors, which is placed at the time of tumor resection. This technology minimizes radiation exposure to healthy tissue, reduces side effects, and ensures 100% treatment compliance, ultimately delaying tumor recurrence and potentially extending patient survival.
Funding: $110.2M
Rough estimate of the amount of funding raised
Funding: $110.2M
Rough estimate of the amount of funding raised
Nature’s Toolbox offers a benchtop, cell-free biomanufacturing platform that produces high-quality RNA, including mRNA and saRNA, in a scalable and efficient manner. This technology addresses the challenges of high costs and lengthy production times in the development of vaccines and therapeutics, enabling faster access to critical biologic materials.
Funding: $60.5M
Rough estimate of the amount of funding raised
Funding: $60.5M
Rough estimate of the amount of funding raised
Pyx Health is a mobile platform that combines an engaging app experience with compassionate staff to provide 24/7 support for individuals experiencing loneliness and social isolation. By identifying vulnerable users, the solution delivers timely companionship and care, resulting in a 55% reduction in loneliness and significant savings in healthcare costs.
Showing 3 of 3 unmatched portfolio companies